This is filed to report recurrent tricuspid regurgitation, single leaflet device attachment/ slda), medical intervention, it was reported in an article review that this was a mitraclip procedure to treat tricuspid regurgitation (tr).An ntr clip delivery system (cds) was advanced to the tricuspid valve for off label use, and the clip was deployed.However, the clip became detached from one leaflet, but remained attached to the other leaflet (single leaflet device attachment/ slda) due to challenging imaging.A 30-day follow up revealed that the patient had recurrent tr which was treated through medical management.No additional information was provided.
|
The udi is unknown because the part number and lot number were not provided.The device was not returned for analysis.Reviews of the lot history record and of similar complaints could not be performed as lot and part numbers were not provided.Based on the available information, the single leaflet device attachment/slda appears to be due to procedural conditions.A cause for the reported poor imaging could not be determined.The reported tricuspid regurgitation (tr) appears to be a cascading event of the slda.The reported additional therapy/non-surgical treatment was a result of case-specific circumstances.It should be noted that per the mitraclip system instructions for use states: ¿the mitraclip system is indicated for the percutaneous reduction of significant symptomatic degenerative mitral regurgitation (mr).¿ since the mitraclip device was implanted on a tricuspid valve, this is considered as an off-label use of the device.However, the off-label use does not appear to have contributed to the reported patient effects.There is no indication of a product issue with respect to manufacture, design, or labeling.Na.
|